Teva Exec Matthew Shields Buys 16,195 Shares, Signaling Management’s Optimism Amid Rising Earnings and Strong Generic Pipeline
Teva insider Matthew Shields buys shares, signaling confidence and steady growth despite a modest trade size – a subtle yet clear sign of executive optimism.
3 minutes to read